Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.5c10486 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Yan Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yancheng Teachers University, Yancheng 224002, China. Hauptthemen laut MEDLINE: Doxorubicin, Drug Resistance, Neoplasm, Dexamethasone, Methyltransferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Suzhou Municipal Science and Technology Bureau, Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu Provincial Department of Education.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Yancheng Teachers University, Yancheng 224002, China.
- Department of Pharmaceutics, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.
- Department of Pharmacy, Children's Hospital of Soochow University, Suzhou 215003, China.
- Children's Hospital of Wujiang District, Suzhou 215200, China.
ORCID-Profile: Xuenong Zhang
Förderung
- Suzhou Municipal Science and Technology Bureau
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Jiangsu Provincial Department of Education
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Research Hospital Association for Precision Medication
Zitieren
APA
Tang, Y., Jia, C., Ning, H., Zhao, Y., Chang, Q., Song, W., Jin, T., & Zhang, X. (2025). Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c10486
Vancouver
Tang Y, Jia C, Ning H, Zhao Y, Chang Q, Song W, et al. Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c10486
BibTeX
@article{Tang2025,
author = {Tang, Yan and Jia, Changhao and Ning, Honglong and Zhao, Ying and Chang, Qingcheng and Song, Wenlin and Jin, Taiwei and Zhang, Xuenong},
title = {Breaking Tumor Chemoresistance via METTL3 Regulation Enhanced by Sequential Delivery of Dexamethasone},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.5c10486}
}
EUVIMED